Publication date: Available online 7 October 2026 Source: The Lancet Infectious Diseases Author(s): Mulenga Mwenda, Rafael Oliveira, Brenda Mambwe, Carol Chiyesu, Bernd Bohmeier, Karolina Mosler, Miller Phiri, Andy Sinyoolo, Virginia Chiposa, Tupilwe Sichone, Memory Munsanje, Mathews Ilunga, Chitundu Chirwa, Innocent Mwape, Donald Mumba, Romain Coppée, Maria-Alexandra Stoica, Maria Isabel Veiga, Chris Drakeley, Richard Pearson
Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1473309926004780?dgcid=rss_sd_all
Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S1473309926004780?dgcid=rss_sd_all
“Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study.” The Lancet Infectious Diseases.
@article{article95384,
title = {Evidence of artemisinin partial resistance in Zambia: a molecular epidemiology and clinical study},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1473309926004780?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...